Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001
-
Shares outstanding
-
33,945,050
-
Total 13F shares
-
1,600
-
Share change
-
0
-
Total reported value
-
$4,352
-
Price per share
-
$2.72
-
Number of holders
-
1
Institutional Holders of Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE) as of Q4 2023
As of 31 Dec 2023,
Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
1,600 shares.
The largest 1 holders included
Financial Gravity Asset Management, Inc..
This page lists
1
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.